Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant

Abstract The D614G mutation in the Spike protein of the SARS-CoV-2 has effectively replaced the early pandemic-causing variant. Using pseudotyped lentivectors, we confirmed that the aspartate replacement by glycine in position 614 is markedly more infectious. Molecular modelling suggests that the G6...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sten Ilmjärv, Fabien Abdul, Silvia Acosta-Gutiérrez, Carolina Estarellas, Ioannis Galdadas, Marina Casimir, Marco Alessandrini, Francesco Luigi Gervasio, Karl-Heinz Krause
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/425fb19c933a4ad18acbebcbf3e961d0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:425fb19c933a4ad18acbebcbf3e961d0
record_format dspace
spelling oai:doaj.org-article:425fb19c933a4ad18acbebcbf3e961d02021-12-02T18:18:58ZConcurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant10.1038/s41598-021-91662-w2045-2322https://doaj.org/article/425fb19c933a4ad18acbebcbf3e961d02021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91662-whttps://doaj.org/toc/2045-2322Abstract The D614G mutation in the Spike protein of the SARS-CoV-2 has effectively replaced the early pandemic-causing variant. Using pseudotyped lentivectors, we confirmed that the aspartate replacement by glycine in position 614 is markedly more infectious. Molecular modelling suggests that the G614 mutation facilitates transition towards an open state of the Spike protein. To explain the epidemiological success of D614G, we analysed the evolution of 27,086 high-quality SARS-CoV-2 genome sequences from GISAID. We observed striking coevolution of D614G with the P323L mutation in the viral polymerase. Importantly, the exclusive presence of G614 or L323 did not become epidemiologically relevant. In contrast, the combination of the two mutations gave rise to a viral G/L variant that has all but replaced the initial D/P variant. Our results suggest that the P323L mutation, located in the interface domain of the RNA-dependent RNA polymerase, is a necessary alteration that led to the epidemiological success of the present variant of SARS-CoV-2. However, we did not observe a significant correlation between reported COVID-19 mortality in different countries and the prevalence of the Wuhan versus G/L variant. Nevertheless, when comparing the speed of emergence and the ultimate predominance in individual countries, it is clear that the G/L variant displays major epidemiological supremacy over the original variant.Sten IlmjärvFabien AbdulSilvia Acosta-GutiérrezCarolina EstarellasIoannis GaldadasMarina CasimirMarco AlessandriniFrancesco Luigi GervasioKarl-Heinz KrauseNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sten Ilmjärv
Fabien Abdul
Silvia Acosta-Gutiérrez
Carolina Estarellas
Ioannis Galdadas
Marina Casimir
Marco Alessandrini
Francesco Luigi Gervasio
Karl-Heinz Krause
Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
description Abstract The D614G mutation in the Spike protein of the SARS-CoV-2 has effectively replaced the early pandemic-causing variant. Using pseudotyped lentivectors, we confirmed that the aspartate replacement by glycine in position 614 is markedly more infectious. Molecular modelling suggests that the G614 mutation facilitates transition towards an open state of the Spike protein. To explain the epidemiological success of D614G, we analysed the evolution of 27,086 high-quality SARS-CoV-2 genome sequences from GISAID. We observed striking coevolution of D614G with the P323L mutation in the viral polymerase. Importantly, the exclusive presence of G614 or L323 did not become epidemiologically relevant. In contrast, the combination of the two mutations gave rise to a viral G/L variant that has all but replaced the initial D/P variant. Our results suggest that the P323L mutation, located in the interface domain of the RNA-dependent RNA polymerase, is a necessary alteration that led to the epidemiological success of the present variant of SARS-CoV-2. However, we did not observe a significant correlation between reported COVID-19 mortality in different countries and the prevalence of the Wuhan versus G/L variant. Nevertheless, when comparing the speed of emergence and the ultimate predominance in individual countries, it is clear that the G/L variant displays major epidemiological supremacy over the original variant.
format article
author Sten Ilmjärv
Fabien Abdul
Silvia Acosta-Gutiérrez
Carolina Estarellas
Ioannis Galdadas
Marina Casimir
Marco Alessandrini
Francesco Luigi Gervasio
Karl-Heinz Krause
author_facet Sten Ilmjärv
Fabien Abdul
Silvia Acosta-Gutiérrez
Carolina Estarellas
Ioannis Galdadas
Marina Casimir
Marco Alessandrini
Francesco Luigi Gervasio
Karl-Heinz Krause
author_sort Sten Ilmjärv
title Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
title_short Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
title_full Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
title_fullStr Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
title_full_unstemmed Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
title_sort concurrent mutations in rna-dependent rna polymerase and spike protein emerged as the epidemiologically most successful sars-cov-2 variant
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/425fb19c933a4ad18acbebcbf3e961d0
work_keys_str_mv AT stenilmjarv concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT fabienabdul concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT silviaacostagutierrez concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT carolinaestarellas concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT ioannisgaldadas concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT marinacasimir concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT marcoalessandrini concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT francescoluigigervasio concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
AT karlheinzkrause concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant
_version_ 1718378150812975104